Efficacy and safety of luseogliflozin as monotherapy in Japanese patients with type 2 diabetes mellitus: a randomized, double-blind, placebo-controlled, phase 3 study - Seino, Y; Fukatsu, A; Ubukata, M (Curr Med Res Opin, 2014)
et al.